The Role of Salvage Chemotherapy on Survival Outcomes Following Immune Checkpoint Inhibitor Therapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

In Vivo · 2025 · PMC12396031 · PMID 40877167

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep =0.06so close (0.05 < p ≤ 0.1)

Patients aged ≥75 years tended to have a poorer prognosis, although this did not reach statistical significance ( p =0.06) ( Figure 4 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.